Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Japan's Suga urges citizens to have a quiet and distanced New Year

Fri, 25th Dec 2020 04:37

(Updates with reports on first cases of mutated coronavirus)

By Kiyoshi Takenaka and Tetsushi Kajimoto

TOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide
Suga urged the nation on Friday to spend a quiet New Year period
without the usual social gatherings to prevent the spread of
COVID-19, which has been breaking infection records almost on a
daily basis.

Suga also announced a package of $2.6 billion for hospitals
treating COVID-19 patients which have come under strain due to
the rapid rise in cases across the northern island of Hokkaido
as well as large cities like Tokyo and Osaka.

"I want you to spend a quiet New Year," the premier told a
news conference in Tokyo with the government's leading
coronavirus expert Shigeru Omi.

"The infections aren't coming down and if we keep going like
this, we won't be able to avoid further spread of the virus."

The country confirmed its first cases of the new, faster-
spreading variant of the virus, in two citizens who had arrived
from the United Kingdom, domestic media reported late on Friday.

Japan has banned entry from United Kingdom, with the
exception of returning Japanese nationals and those with
residence permits.

Japan does not celebrate Christmas, but the New Year period
is an extended national holiday, with many people usually
travelling back to their hometowns and spending time with family
and friends.

Omi warned that it was critical that "all citizens move in
the same direction," to get a grip on the health crisis.

"If we don't bring infections down now, once they surge
again after the New Year period it won't be easy to change the
downward trend," he said. "It would take time, and would
probably be impossible to control over a period of weeks," he
said.

Omi said shared meals were a major cause of infections and
called on people to refrain from holding large gatherings and to
limit meals to four people one regularly ate with, or fewer.

While Japan has avoided the huge infection numbers seen in
other parts of the world, the number of new daily cases
surpassed 3,000 for the first time this month. Tokyo reported
884 infections on Friday, near Thursday's record 888.

HOSPITALS, VACCINES

Underscoring the strain on the hospitals, five national
groups of doctors and other medical workers made an emergency
request to Suga on Friday, asking for strong anti-pandemic
measures and support for the medical sector.

With hospitals equipped for treating COVID-19 filling up,
other hospitals are being forced to accept patients with the
disease, according to Tsuyoshi Masuda, president of the Japan
Federation of Democratic Medical Institutions.

"These small and medium-sized hospitals, which have been
supporting medical services in their respective regions, are
facing a crisis that is threatening their survival," Masuda told
reporters at a separate news conference on Friday.

He also warned that the risk of in-hospital infections was
high at institutions not specialized in dealing with infectious
diseases.

Japan, with a population of 126 million, has struck deals
to buy 290 million vaccine doses from Pfizer Inc,
AstraZeneca Plc and Moderna Inc, or enough for
145 million people.

A health ministry panel said that people aged 65 or older
should get priority for vaccination against COVID-19, as well as
frontline healthcare workers and people with underlying medical
conditions.

It specified chronic heart disease, chronic respiratory
disease and chronic kidney disease, among others, as underlying
conditions that should determine priority.

The panel's recommendations would mean 36 million elderly
people and 8.2 million people with medical conditions would be
the first to receive shots.
(Reporting by Kiyoshi Takenaka, Ju-min Park, Testsushi Kajimoto
and Antoni Slodkowski; Editing by Shri Navaratnam, Edmund
Klamann and William Mallard)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.